Does SITAGLIPTIN Cause Metastatic neoplasm? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Metastatic neoplasm have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.
22
Reports of Metastatic neoplasm with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
19
Deaths
20
Hospitalizations
How Dangerous Is Metastatic neoplasm From SITAGLIPTIN?
Of the 22 reports, 19 (86.4%) resulted in death, 20 (90.9%) required hospitalization, and 10 (45.5%) were considered life-threatening.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which SITAGLIPTIN Alternatives Have Lower Metastatic neoplasm Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE